![4-Hydroxy-N-(4-methoxy-7-morpholinobenzo[d]thiazol-2-yl)-4-methylpiperidine-1-carboxamide](https://static.cymitquimica.com/products/3D/img/VJB07055.png "Clique para ampliar")
4-Hydroxy-N-(4-methoxy-7-morpholinobenzo[d]thiazol-2-yl)-4-methylpiperidine-1-carboxamide
CAS: 870070-55-6
Ref. 3D-VJB07055
| 5mg | A consultar | ||
| 10mg | A consultar | ||
| 25mg | A consultar | ||
| 50mg | A consultar | ||
| 100mg | A consultar |
Informação sobre produto
- Tozadenant
- 4-Hydroxy-4-Methyl-Piperidine-1-Carboxylic Acid(4-Methoxy-7-Morpholin-4-Yl-Benzothiazol-2-Yl)-Amide
- Syn-115
- 4-Hydroxy-N-(4-Methoxy-7-(4-Morpholinyl)-2-Benzothiazolyl)-4-Methyl-1-Piperidinecarboxamide
- Tozadenant (USAN)
- 4-Hydroxy-N-(4-methoxy-7-morpholinobenzo(d)thiazol-2-yl)-4-methylpiperidine-1-carboxamide
4-Hydroxy-N-(4-methoxy-7-morpholinobenzo[d]thiazol-2-yl)-4-methylpiperidine-1-carboxamide is a novel, potent, and selective adenosine receptor antagonist. It has been shown to be well tolerated in preclinical models and demonstrate efficacy in animal models of infectious diseases. Preclinical studies have also demonstrated that administration of this drug results in a stable plasma concentration with a low incidence of adverse effects. Clinical trials are currently underway to evaluate the safety and efficacy of this drug for the treatment of cancer and other diseases.
Propriedades químicas
Consulta técnica sobre: 3D-VJB07055 4-Hydroxy-N-(4-methoxy-7-morpholinobenzo[d]thiazol-2-yl)-4-methylpiperidine-1-carboxamide
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.
